What were the main drivers of 3M's sales growth in the first quarter of 2010?

3M's sales growth in Q1 2010 was driven by a combination of factors including a broad economic recovery, strong performance in emerging economies (particularly Asia Pacific and Latin America/Canada), significant organic sales volume growth of 19.2%, market share gains, successful new product introductions, and favorable currency translation effects.

What is the impact of the new healthcare legislation on 3M's financial results?

The Patient Protection and Affordable Care Act, enacted in March 2010, resulted in a one-time, non-cash income tax charge of $84 million (approximately $0.11 per diluted share). This charge was due to a reduction in the value of the company's deferred tax asset related to changes in the tax treatment of Medicare Part D reimbursements.

How is 3M managing its financial condition and liquidity?

3M maintained a strong financial position with $1.08 billion in operating cash flow for the quarter. The company has ample liquidity, with $5.2 billion in cash, cash equivalents, and marketable securities, and a manageable debt level. They continue to invest in growth, consider acquisitions, and return capital to shareholders through dividends and share repurchases, while maintaining strong credit ratings.

MMM 10-Q Quarterly Report Q1 FY2010 — Revenue, Net Income, EPS

Q: How did the company's profitability change compared to the previous year?

Profitability improved significantly, with operating income increasing by 79.9% to $1.45 billion. This was due to higher sales volumes, improved factory utilization, cost savings from prior restructuring initiatives, and increased operational efficiencies, leading to a substantial expansion in operating income margins from 15.8% in Q1 2009 to 22.8% in Q1 2010.

Summary

3M Company reported a strong first quarter in 2010, with net sales of $6.35 billion, a significant increase of 24.7% compared to the same period in 2009. This growth was driven by broad-based improvements across all business segments and geographic regions, with particular strength in Asia Pacific and Latin America/Canada. The company experienced robust organic sales volume growth of 19.2%, outpacing global economic indicators and suggesting market share gains supported by new products and technologies. Profitability also saw substantial improvement, with operating income rising by 79.9% to $1.45 billion. This was achieved through a combination of increased sales, improved factory utilization, cost savings from prior restructuring actions, and enhanced operational efficiencies. The company's effective tax rate increased slightly to 31.9% due to a one-time non-cash tax charge related to the new healthcare legislation, but underlying international tax benefits and other adjustments helped manage the overall rate. 3M maintained a strong financial position with healthy operating cash flows of $1.08 billion and ample liquidity.

Financial Highlights

52 data points

Beta

Revenue

$6.35B

0.5% Gross Margin

Net Income

$930.00M

0.1% Net Margin

EPS (Diluted)

$1.29

Total Assets

$28.02B

Cash & Equivalents

$2.85B

Free Cash Flow

$925.00M

Financial Statements

Beta

Revenue	$6.35B
Cost of Revenue	$3.24B
Gross Profit	$3.11B
SG&A Expenses	$1.32B
Operating Expenses	$4.90B
Operating Income	$1.45B
Net Income	$930.00M
EPS (Basic)	$1.31
EPS (Diluted)	$1.29
Shares Outstanding (Basic)	711.80M
Shares Outstanding (Diluted)	723.50M

Key Highlights

1Net sales increased by a significant 24.7% to $6.35 billion in Q1 2010 compared to Q1 2009.
2Operating income saw a substantial rise of 79.9% to $1.45 billion, indicating strong margin expansion.
3Organic sales volume grew by 19.2%, demonstrating robust demand and potential market share gains.
4All six business segments reported strong sales growth, with Display and Graphics, Electro and Communications, and Industrial and Transportation leading the way.
5The company generated $1.08 billion in cash from operating activities, reflecting strong cash generation capabilities.
6A one-time, non-cash income tax charge of $84 million (or $0.11 per diluted share) was recorded due to the Patient Protection and Affordable Care Act.
73M continues to invest in growth initiatives, including R&D and acquisitions, while maintaining a disciplined approach to capital allocation.

3M CO Quarterly Report for Q1 Ended Mar 31, 2010

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions